Zinerite pore. prigot. r-ra d / nar. approx. complete with solvent and applicator 30 ml # 1

Dosage form

Powder for solution preparation for external use.

Structure:

Erythromycin 1.2 g

zinc acetate dihydrate micronized 360 mg

Solvent: diisopropyl sebacate, ethanol.

pharmachologic effect

Erythromycin-zinc complex.

It has anti-inflammatory, antimicrobial and comedolytic effects.

Erythromycin acts bacteriostatically against the microorganisms that cause acne: Propionibacterium acnes and Staphylococcus epidermidis.

Zinc reduces the secretion of the sebaceous glands, has an astringent effect.

Pharmacokinetics

The complex connection of the components of the preparation ensures good penetration of active substances into the skin.

Zinc mainly binds to the follicular epithelium and is not resorbed into the systemic circulation.

A small part of erythromycin undergoes systemic absorption and is subsequently excreted from the body.

Side effects

Local reactions: sometimes there may be a burning sensation, irritation, dry skin at the site of application of the drug.

As a rule, these phenomena are mild and do not require discontinuation of the drug and / or symptomatic therapy.

Selling features

Available without a prescription

Special conditions

When using the drug, one should take into account the possibility of cross-resistance to other antibiotics of the macrolide group, lincomycin, clindamycin.

Avoid getting the drug in the eyes or on the mucous membrane of the mouth and nose, because

it can cause irritation and burns.

Indications for the treatment of acne.

Contraindications

- hypersensitivity to erythromycin and other macrolides

- hypersensitivity to zinc or other components of the drug.

Drug interactions To date, no clinically significant interaction of Zinerit with other drugs has been established.

Name ENG

ZINERYT

Clinical and pharmacological group

A drug with antibacterial and comedolytic action for the treatment of acne

ATX code

Erythromycin in combination with other drugs

Dosage

360mg / 30ml + 1200mg / 30ml

Structure

Erythromycin 1.2 g, micronized zinc acetate dihydrate 360 ​​mg.

Solvent: diisopropyl sebacate, ethanol.

Indications

Acne

INN / Active ingredient

Erythromycin, zinc acetate basic

Contraindications

Hypersensitivity to erythromycin and other macrolides

hypersensitivity to zinc or other components of the drug.

Storage conditions and periods

At a temperature of 15-20 degrees.

Expiration date: 3 years

Specifications

Category

Acne

Scope of the drug

Leather

Release form

Powder

Manufacturer country

Netherlands

Package quantity, pcs

one

Way of introduction

On the skin

Vacation conditions

Without recipe

Brand name

ASTELLAS

Components

applicator, solvent (bottle)

The amount of the dosage form in the primary package

1 PC.

Primary packaging type

Plastic bottle

Type of consumer packaging

Cardboard box

Pharmaco-therapeutic group

Acne rash treatment

Anatomical and therapeutic characteristics

D10AF52 Erythromycin, in combination with other drugs

Dosage form

Powder for solution preparation for external use

Expiration date in days

1095

Package weight, g

60

Mode of application

:

The drug is used externally.

Using the supplied applicator, the prepared Zinerite solution is applied in a thin layer to the affected skin area 2: in the morning (before applying makeup) and in the evening (after washing).

The drug should be applied by tilting the bottle with the prepared solution downward, with light pressure.

The rate of application of the solution is regulated by the force of pressing the applicator on the skin.

An approximate single dose is 0.5 ml.

After drying, the solution becomes invisible.

< br> The duration of the course is 10-12 weeks.

In some cases, clinical improvement occurs within 2 weeks.

Dosage (volume) of the substance in the preparation

:

Erythromycin 1.2 g, zinc acetate dihydrate micronized 360 mg